Varex Imaging (NASDAQ:VREX) issued an update on its FY18 earnings guidance on Tuesday morning. The company provided EPS guidance of $1.25-1.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.32. The company issued revenue guidance of $755-780 million, compared to the consensus revenue estimate of $760.50 million.Varex Imaging also updated its FY 2019 guidance to $1.25-1.55 EPS.

NASDAQ VREX traded down $0.66 on Tuesday, reaching $26.11. 889,352 shares of the company were exchanged, compared to its average volume of 287,589. The firm has a market capitalization of $1.04 billion, a P/E ratio of 14.51, a price-to-earnings-growth ratio of 1.71 and a beta of 1.58. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.42 and a current ratio of 3.16. Varex Imaging has a fifty-two week low of $24.06 and a fifty-two week high of $43.76.

Varex Imaging (NASDAQ:VREX) last released its quarterly earnings data on Tuesday, November 13th. The company reported $0.29 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.30 by ($0.01). The company had revenue of $204.80 million for the quarter, compared to analyst estimates of $192.10 million. Varex Imaging had a return on equity of 15.16% and a net margin of 5.39%. The business’s quarterly revenue was down 5.1% on a year-over-year basis. During the same period last year, the firm posted $0.59 EPS. As a group, sell-side analysts forecast that Varex Imaging will post 1.33 EPS for the current year.

Several brokerages have recently commented on VREX. ValuEngine raised Varex Imaging from a hold rating to a buy rating in a research note on Thursday, July 26th. TheStreet lowered Varex Imaging from a c- rating to a d+ rating in a research note on Friday, October 26th. Zacks Investment Research raised Varex Imaging from a strong sell rating to a hold rating in a research note on Thursday, October 4th. Finally, Jefferies Financial Group decreased their price target on Varex Imaging to $33.00 and set a buy rating on the stock in a research note on Friday, August 3rd. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of $37.00.

In other Varex Imaging news, CFO Clarence R. Verhoef purchased 3,300 shares of the firm’s stock in a transaction dated Friday, August 17th. The shares were acquired at an average price of $29.58 per share, with a total value of $97,614.00. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at

Varex Imaging Company Profile

Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers, and buckys.

Featured Article: How to Invest in the Dividend Aristocrat Index

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with's FREE daily email newsletter.